Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020 Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
News

OPEN Health reveals new CEO appointment

November 19, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
News
lilly_building_with_american_flag_web

NICE recommends Lilly’s Emgality for chronic and episodic migraine

November 18, 2020 Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
News
moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
News
512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
News

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020 Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
News
flu_vaccination_grippe_5115654021_2

British Labour Party calls for new laws to tackle online anti-vaxx campaigns

November 16, 2020 Sales and Marketing

The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …
News
obsessive_compulsive_disorder_8970250666

Antidepressants could treat coronavirus, new study suggests

November 16, 2020 Sales and Marketing

The antidepressant fluvoxamine could treat COVID-19 patients and stop their symptoms from worsening, according to a new study. 
News
1200px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

UK Prime Minister Boris Johnson self-isolating after meeting an MP who had COVID-19

November 16, 2020 Sales and Marketing

The British Prime Minister Boris Johnson has begun working in self isolation after coming into contact with an MP who …
News
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
News

NICE recommends Sanofi’s Cablivi for ultra-rare acute thrombotic thrombocytopenic purpura

November 12, 2020 Sales and Marketing NHS, NICE, Sanofi, pharma

Sanofi’s Cablivi (caplacizumab) has received recommendation from NICE for routine NHS use in England and Wales for the treatment of …
News
steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020 Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …
News
nice_reception_2

NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia

November 10, 2020 Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax

NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …
News
stethoscope_and_background_doctor

Scottish Medicines Consortium greenlights Nubeqa for prostate cancer

November 10, 2020 Manufacturing and Production, Sales and Marketing

The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …
News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020 Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025